By this time, AβPP-derived iAβ has crossed the T1 in all affected neurons of the AD patient, the ISR has been elicited, and the AβPP-independent iAβ production pathway has been rendered operational; iAβ is rapidly accumulating and its levels have crossed the T2 threshold in a fraction of the neurons. This evidence concerns the gene APP and Alzheimer disease.